Please login to the form below

Not currently logged in
Email:
Password:

Zyban

This page shows the latest Zyban news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

Pfizer’ s Champix and GSK’ s Zyban cleared of causing neuropsychiatric side effects. ... They also found that smokers treated with Champix had significantly higher quit rates than those treated with Zyban, nicotine patch or placebo.

Latest news

  • Study clears Pfizer’s Champix of serious risks Study clears Pfizer’s Champix of serious risks

    The study, published in The Lancet Respiratory Medicine, followed over 160, 000 patients for five years who received nicotine replacement therapy (NRT), GlaxoSmithKline's anti-smoking drug Zyban (bupropion) or ... The researchers found that people taking

  • FDA boxed warnings for Chantix and Zyban

    FDA boxed warnings for Chantix and Zyban. The US FDA has announced a requirement for manufacturers to put a boxed warning on the prescribing information for Chantix and Zyban. ... Some of the symptoms experienced by patients using Chantix and Zyban may

  • Pfizer smoking cessation drug approved in US

    The prescription-only product, Chantix (varenicline), is set to do battle with GlaxoSmithKline's Zyban (bupropion) in the US market. ... Forty-four per cent of Chantix patients managed to give up the habit, compared with 30 per cent who took Zyban.

  • R&D news in brief

    receptors. Despite smokers who use nicotine patches or Zyban being twice as likely to succeed at giving up the habit as those who don't use medications, more than 80 per

  • Hard habit to break

    More than three in four of those who set a date received Nicotine Replacement Therapy (NRT), 30, 200 (8 per cent) received Zyban and 3, 800 (1 per cent) received both ... A national telephone helpline. Nicotine Replacement Therapy and Zyban on

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics